Cargando…
In vitro thymidine labelling of human pulmonary neoplasms.
The in vitro thymidine labelling indices (TLI) of 58 human lung tumours were assessed using autoradiography. The labelling technique involved incubation of 1 mm3 tumour fragments with 3H-thymidine (5 muCi ml-1) under conditions of hyperbaric oxygenation at a pressure of 3 atmospheres. Only a rim of...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011269/ https://www.ncbi.nlm.nih.gov/pubmed/6824569 |
_version_ | 1782136496090775552 |
---|---|
author | Kerr, K. M. Robertson, A. M. Lamb, D. |
author_facet | Kerr, K. M. Robertson, A. M. Lamb, D. |
author_sort | Kerr, K. M. |
collection | PubMed |
description | The in vitro thymidine labelling indices (TLI) of 58 human lung tumours were assessed using autoradiography. The labelling technique involved incubation of 1 mm3 tumour fragments with 3H-thymidine (5 muCi ml-1) under conditions of hyperbaric oxygenation at a pressure of 3 atmospheres. Only a rim of labelling was achieved along the edges of fragments and the depth of this rim varied from tumour to tumour. A technique for counting TLIs was therefore devised to take this into account. In general, those tumours showing low TLI values of less than 5.0% showed a greater depth of labelling. The common malignant tumours of the bronchus showed a wide range of values (2.2-30.4%) though the adenocarcinomata had a lower average value than the other groups. With the squamous carcinomata a relationship with differentiation was shown. The mean value for small cell carcinomata (16.9%)--a highly aggressive tumour--was no higher than for the other groups. The low grade malignant tumours showed TLIs of less than 3.0% and these values correlate with their less aggressive clinical behaviour. Labelling of stromal cells and inflammatory cells varied greatly from tumour to tumour; however, no correlation was found with the TLIs of tumour cells. |
format | Text |
id | pubmed-2011269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1983 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20112692009-09-10 In vitro thymidine labelling of human pulmonary neoplasms. Kerr, K. M. Robertson, A. M. Lamb, D. Br J Cancer Research Article The in vitro thymidine labelling indices (TLI) of 58 human lung tumours were assessed using autoradiography. The labelling technique involved incubation of 1 mm3 tumour fragments with 3H-thymidine (5 muCi ml-1) under conditions of hyperbaric oxygenation at a pressure of 3 atmospheres. Only a rim of labelling was achieved along the edges of fragments and the depth of this rim varied from tumour to tumour. A technique for counting TLIs was therefore devised to take this into account. In general, those tumours showing low TLI values of less than 5.0% showed a greater depth of labelling. The common malignant tumours of the bronchus showed a wide range of values (2.2-30.4%) though the adenocarcinomata had a lower average value than the other groups. With the squamous carcinomata a relationship with differentiation was shown. The mean value for small cell carcinomata (16.9%)--a highly aggressive tumour--was no higher than for the other groups. The low grade malignant tumours showed TLIs of less than 3.0% and these values correlate with their less aggressive clinical behaviour. Labelling of stromal cells and inflammatory cells varied greatly from tumour to tumour; however, no correlation was found with the TLIs of tumour cells. Nature Publishing Group 1983-02 /pmc/articles/PMC2011269/ /pubmed/6824569 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Kerr, K. M. Robertson, A. M. Lamb, D. In vitro thymidine labelling of human pulmonary neoplasms. |
title | In vitro thymidine labelling of human pulmonary neoplasms. |
title_full | In vitro thymidine labelling of human pulmonary neoplasms. |
title_fullStr | In vitro thymidine labelling of human pulmonary neoplasms. |
title_full_unstemmed | In vitro thymidine labelling of human pulmonary neoplasms. |
title_short | In vitro thymidine labelling of human pulmonary neoplasms. |
title_sort | in vitro thymidine labelling of human pulmonary neoplasms. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011269/ https://www.ncbi.nlm.nih.gov/pubmed/6824569 |
work_keys_str_mv | AT kerrkm invitrothymidinelabellingofhumanpulmonaryneoplasms AT robertsonam invitrothymidinelabellingofhumanpulmonaryneoplasms AT lambd invitrothymidinelabellingofhumanpulmonaryneoplasms |